Current issues in the histopathology of gestational trophoblastic tumors

Fetal and Pediatric Pathology

Volumn 29, Issue 1, 2010, Pages 30-44

  Sebire, N J ^a   Lindsay, Iain ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Choriocarcinoma; HCG; Placental site trophoblastic tumour

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; ERLOTINIB; ETOPOSIDE; FOLINIC ACID; GEMCITABINE; IRINOTECAN; METHOTREXATE; PEMETREXED; SORAFENIB; TOPOTECAN; VANDETANIB; VINCRISTINE;

CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CLINICAL FEATURE; COMPLETE HYDATIDIFORM MOLE; CONCENTRATION (PARAMETERS); ECTOPIC CHORIOCARCINOMA; EPITHELIOID TROPHOBLASTIC TUMOR; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; INTRAPLACENTAL CHORIOCARCINOMA; MALIGNANT GESTATIONAL TROPHOBLASTIC TUMOR; METASTASIS; MOTHER; MULTIPLE CYCLE TREATMENT; PARTIAL HYDATIDIFORM MOLE; PLACENTAL SITE TROPHOBLASTIC TUMOR; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; TROPHOBLAST; TROPHOBLASTIC TUMOR; UNSPECIFIED SIDE EFFECT; UTERINE CHORIOCARCINOMA; UTERUS CANCER;

FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; PREGNANCY;

EID: 75149186968     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513810903266120     Document Type: Review

References (47)

1. Covone AE, Mutton D, Johnson PM, Adinolfi M. Trophoblast cells in peripheral blood from pregnant women. Lancet ii:841-843, 1984.
2. Fox H, Sebire NJ. Pathology of the Placenta. London: Elsevier, 2007.
3. Wells M, Bulmer JN. The human placental bed: histology, immunohistochemistry and pathology. Histopathology 13:483-498, 1988.
4. Shih IM, Kurman R. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22:1393-1403, 1998.
5. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In Haines and Taylor: Textbook of Obstetrical and Gynaecological Pathology, 5th ed. Fox H, Wells M, eds., Edinburgh: Churchill Livingstone. pp. 1359-1430, 2003.
6. World Health Organization Scientific Group. Gestational trophoblastic diseases. Technical Report Series 692, 1983.
7. Fisher RA, Newlands ES, Jeffreys AJ, et al. Gestational and non-gestational trophoblastic tumors distinguished by DNA analysis. Cancer 69:839-845, 1992.
8. Fisher RA, Soteriou BA, Meredith L, Paradinas FH, Newlands ES. Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins. Int J Gynecol Cancer 5:64-70, 1995.
9. Newlands ES. The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN). Best Pract Res Clin Obstet Gynaecol 6:905-923, 2003.
10. Mazur MT. Metastatic gestational choriocarcinoma: unusual pathological variant following therapy. Cancer 50:1370-1377, 1989.
11. Ober WB, Maier RC. Gestational choriocarcinoma of the fallopian tube. Diagn Gynecol Obstet 3:213-231, 1981.
12. Kuida CA, Braunstein GD, Shintaku P, Said JW. Human chorionic gonadotropin expression in lung, breast and renal carcinomas. Arch Pathol Lab Med 112:282-285, 1988.
13. Paradinas FJ, Fisher RA. Pathology and molecular genetics and trophoblastic disease. Curr Obstet Gynaecol 5:6-12, 1995.
14. Sebire NJ, Lindsay I, Fisher RA, Seckl MJ. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol 24:21-29, 2005.
15. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 20:32-47, 2001.
16. Young RH, Kurman RJ, Scully RE. Proliferations and tumors of the placental site. Semin Diagn Pathol 5:223-237, 1988.
17. Young RH, Kurman RJ, Scully RE. Placental site nodules and plaques: a clinicopathological analysis of 20 cases. Am J Surg Pathol 14:1001-1009, 1990.
18. Kouvidou C, Karayianni M, Liapi-Avgeri G, Toufexi H, Karaiossifid H. Old ectopic pregnancy remnants with morphological features of placental site nodule occurring in fallopian tube and broad ligament. Pathol Res Pract 196:329-332, 2000.
19. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Patho 18:144-150, 1999.
20. Shih IM, Kurman RJ. Ki-67 labelling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29:27-33, 1998.
21. Lage JM, Young RH. Pathology of trophoblastic disease. In Tumors and Tumorlike Lesions of the Uterine Corpus and Cervix. Clement PB, Young RH, eds., New York: Churchill Livingstone, pp. 419-475, 1993.
22. Moore-Maxwell CA, Robboy SJ. Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 93:708-712, 2004.
23. McLellan R, Buscema J, Currie JL, Woodruff JD. Placental site trophoblastic tumor in a postmenopausal woman. Am J Clin Pathol 95:670-675, 1991
24. Papadopoulos AJ, Foskett M, Seckl MJ, et al. Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 47:460-464, 2002.
25. Hassadia A, Gillespie A, Tidy J, Everard J, Wells M, Coleman R, Hancock B. Placental site trophoblastic tumor: clinical features and management. Gynecol Oncol 99:603-607, 2005.
26. Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 102:160-164, 2006.
27. Cole LA, Khanlian SA, Muller CY. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results. J Reprod Med 53:457-464, 2008.
28. Harvey RA, Pursglove HD, Schmid P, Savage PM, Mitchell HD, Seckl MJ. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors. J Reprod Med 53:643-648, 2008.
29. Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100:511-520, 2006. (Pubitemid 43250626)
30. Chang YL, Chang TC, Hsueh S, et al. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol 73:216-222, 1999.
31. Ichikawa N, Zhai YL, Shiowaza T, et al. Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor. Int J Gynecol Pathol 17:235-240, 1998.
32. Kurman RJ, Young RH, Norris HJ, Lawrence WD, Scully RE. Immunocytochemical localization of placental lactogen and chorionic gonadotrophin in the normal placenta and trophoblastic tumors with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3:101-121, 1984.
33. McCluggage WG, Ashe P, McBride H, Maxwell P, Sloan JM. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 32:252-256, 1998.
34. Singer G, Kurman RJ, McMaster M, Shih IM. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26:914-920, 2002.
35. Xue WC, Khoo US, Ngan HYS, et al. C-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions. Int J Gynecol Pathol 23:145-150, 2004.
36. Alvero R, Remmenga S, O'Connor D, Barnhill D, Park R. Metastatic placental site trophoblastic tumor. Gynecol Oncol 37:445-449, 1990.
37. How J, Scurry J, Grant P, et al. Placental site trophoblastic tumor: report of three cases and review of the literature. Int J Gynecol Cancer 5:241-249, 1995.
38. Piura B, Rabinovich A, Meirovitz M, Shaco-Levy R. Placental site trophoblastic tumor: report of four cases and review of literature. Int J Gynecol Cancer 17:258-262, 2007.
39. Coulson LE, Kong CS, Zaloudek C. Epithelioid trophoblastic tumor of the uterus in a postmenopausal woman: a case report and review of the literature. Am J Surg Pathol 24:1558-1562, 2000.
40. Oldt RJ, Kurman RJ, Shih IM. Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol 161:1033-1037, 2002.
41. Ngan H, Wong LC, Ma HK. Staging and classification systems. In Gestational Trophoblastic Disease, 2nd ed., Hancock BW, Newlands ES, Berkowitz RS, Cole LA, eds. www.isstd.org/gtd/contents/chapter6, 2003.
42. Kohorn IE. The FIGO 2000 staging and risk factor scoring system for gestational trophoblastic neoplasia. In Gestational Trophoblastic Disease, 2nd ed., Hancock BW, Newlands ES, Berkowitz RS, Cole LA, eds. www.isstd.org/gtd/ contents/chapter7, 2003.
43. Wong LC, Ngan HY, Cheng DK, Ng TY. Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 183:1579-1582, 2000.
44. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, SecklMJ, Newlands ES. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20:1838-1844, 2002.
45. Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15:2636-2643, 1997.
46. Yang J, Xiang Y, Wan X, Yang X, et al. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment. Gynecol Oncol 103:479-482, 2006.
47. Pfeffer PE, Sebire NJ, Lindsay I, McIndoe A, Lim A, Seckl MJ. Fertility-sparing partial hysterectomy for placental-site trophoblastic tumor. Lancet Oncol 8:744-746, 2007.